ARID2 and neoplasm: There are reports of ARID2 loss-of-function mutations in a wide variety of human malignancies, such as melanoma, gastric adenocarcinoma, non-small cell lung cancer and hepatocellular carcinoma, suggesting its tumour suppressor function [113,117–119,148].